Question-and-Answer SessionSo Mark, maybe for the audience who might be less familiar with the story, can you maybe start setting the stage by giving us an introduction of -- an overview of RevMed, what's the current pipeline and what have kept you busy for the past year?Mark GoldsmithCEO, President & Chairman Yes. Thanks for having us. Revolution Medicines is a company focused essentially exclusively on the most common genetic cause of cancers that is RAS-driven cancer. We have developed a very rich pipeli ...